Experimental drug gives hope for rare disease, autism
Experimental drug gives hope for rare disease, autism
About this item
Full title
Author / Creator
Publisher
McLean: USA Today, a division of Gannett Satellite Information Network, Inc
Journal title
Language
English
Formats
Publication information
Publisher
McLean: USA Today, a division of Gannett Satellite Information Network, Inc
Subjects
More information
Scope and Contents
Contents
While patients in general advanced in their social functioning -- improving their ability to hold conversations or function in groups of people -- those with the most severe social problems got the most benefit, says Paul Wang, vice president of development at Seaside Therapeutics, which funded the trial and is developing the drug. Of 27 patients w...
Alternative Titles
Full title
Experimental drug gives hope for rare disease, autism
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1041251278
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1041251278
